Development of a multi-step leukemogenesis model of MLL-rearranged leukemia using humanized mice

• Published in: PloS one 2012-06, Vol.7 (6), p.e37892-e37892
• Main Authors: Moriya, Kunihiko, Suzuki, Makiko, Watanabe, Yohei, Takahashi, Takeshi, Aoki, Yoko, Uchiyama, Toru, Kumaki, Satoru, Sasahara, Yoji, Minegishi, Masayoshi, Kure, Shigeo, Tsuchiya, Shigeru, Sugamura, Kazuo, Ishii, Naoto
• Format: Article
• Language: English
• Subjects: Animal models; Animals; Biology; Blotting, Southern; Cancer treatment; Cooperation; Cord blood; Disease Models, Animal; Flow Cytometry; Genes; Genomics; Genotype & phenotype; Hematopoiesis; Hematopoietic stem cells; Hematopoietic Stem Cells - cytology; Hematopoietic Stem Cells - metabolism; Humans; Immunodeficiency; Immunology; Interleukin 2 receptors; K-Ras protein; Laboratory animals; Leukemia; Leukemia - genetics; Leukemia - metabolism; Leukemogenesis; Liver; Liver transplants; Medical prognosis; Medicine; Melanoma; Mice; Mutation; Myeloid-Lymphoid Leukemia Protein - genetics; Myeloid-Lymphoid Leukemia Protein - metabolism; Oncogene Proteins, Fusion - genetics; Oncogene Proteins, Fusion - metabolism; Pathogenesis; Pediatrics; Proteins; Reverse Transcriptase Polymerase Chain Reaction; Stem cell transplantation; Stem cells; Transcription Factors - genetics; Transcription Factors - metabolism; Transplantation; University graduates
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0037892

Mixed-lineage-leukemia (MLL) fusion oncogenes are intimately involved in acute leukemia and secondary therapy-related acute leukemia. To understand MLL-rearranged leukemia, several murine models for this disease have been established. However, the mouse leukemia derived from mouse hematopoietic stem cells (HSCs) may not be fully comparable with human leukemia. Here we developed a humanized mouse model for human leukemia by transplanting human cord blood-derived HSCs transduced with an MLL-AF10 oncogene into a supra-immunodeficient mouse strain, NOD/Shi-scid, IL-2Rγ(-/-) (NOG) mice. Injection of the MLL-AF10-transduced HSCs into the liver of NOG mice enhanced multilineage hematopoiesis, but did not induce leukemia. Because active mutations in ras genes are often found in MLL-related leukemia, we next transduced the gene for a constitutively active form of K-ras along with the MLL-AF10 oncogene. Eight weeks after transplantation, all the recipient mice had developed acute monoblastic leukemia (the M5 phenotype in French-American-British classification). We thus successfully established a human MLL-rearranged leukemia that was derived in vivo from human HSCs. In addition, since the enforced expression of the mutant K-ras alone was insufficient to induce leukemia, the present model may also be a useful experimental platform for the multi-step leukemogenesis model of human leukemia.